| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
4,401,607 | 3,605,070 | 3,573,442 | 3,414,371 | 2,776,680 |
| Cost of Revenue
|
-3,522,526 | -2,883,560 | -3,067,878 | -2,935,555 | -2,318,545 |
|
Gross Profit
|
879,081 | 721,510 | 505,564 | 478,816 | 458,135 |
| Selling, General and Administrative Expenses
|
-471,145 | -406,572 | -403,295 | -339,278 | -350,867 |
|
Research and Development Expenses
|
-22,625 | -16,447 | 0 | -1,899 | -7,594 |
|
Operating Income/Expenses
|
-493,770 | -423,019 | -403,295 | -341,177 | -358,461 |
|
Total Operating Profit/Loss
|
385,311 | 298,491 | 102,269 | 137,639 | 99,674 |
| Total Net Finance Income/Expense
|
-28,604 | -30,764 | -40,494 | -44,098 | -53,581 |
| Net Investment Income
|
10,739 | -17,144 | -33,843 | -9,886 | 30,420 |
| Irregular Income/Expenses
|
-1,500 | -6,498 | 2,195 | 19,469 | -10,756 |
|
Other Income/Expense, Non-Operating
|
597,449 | 9,597 | 15,979 | 37,547 | 41,984 |
|
Non-Operating Income/Expenses, Total
|
578,084 | -44,809 | -56,163 | 3,032 | 8,067 |
|
Pretax Income
|
963,395 | 253,682 | 46,106 | 140,671 | 107,741 |
|
Provision for Income Tax
|
-169,941 | -63,607 | -44,629 | -60,351 | -8,228 |
|
Net Income from Continuing Operations
|
793,454 | 190,075 | 1,477 | 80,320 | 99,513 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
793,454 | 190,075 | 1,477 | 80,320 | 99,513 |
|
Non-Controlling/Minority Interests
|
14,995 | 10,585 | 37 | 0 | -- |
|
Net Income after Non-Controlling/Minority Interests
|
808,449 | 200,660 | 1,514 | 80,320 | 99,513 |
|
Net Income Available to Common Stockholders
|
808,449 | 200,660 | 1,514 | 80,320 | 99,513 |
|
Diluted Net Income Available to Common Stockholders
|
808,449 | 200,660 | 1,514 | 80,320 | 99,513 |
| Basic EPS
|
6.58 | 1.77 | 0.02 | 0.87 | 1.21 |
| Diluted EPS
|
6.47 | 1.57 | 0.02 | 0.73 | 1.07 |
|
Basic Weighted Average Shares Outstanding
|
121,597.43 | 113,367.23 | 75,700 | 92,321.84 | 82,242.15 |
|
Diluted Weighted Average Shares Outstanding
|
127,159.74 | 127,808.92 | 75,700 | 110,027.40 | 93,002.80 |
|
EBIT
|
991,999 | 284,446 | 86,600 | 184,769 | 161,322 |
|
EBITDA
|
1,105,631 | 385,884 | 177,562 | 278,574 | 254,079 |
|
Normalized EBITDA
|
604,176 | 414,151 | 189,066 | 249,581 | 295,250 |
|
Normalized Income
|
380,454.66 | 211,254.47 | 10,680.20 | 57,125.60 | 137,539.85 |
|
Total Unusual Items
|
-501,455 | 28,267 | 11,504 | -28,993 | 41,171 |
|
Total Unusual Items Excluding Goodwill
|
-501,455 | 28,267 | 11,504 | -28,993 | 41,171 |
12/31/2022 - 10/3/2012
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade